COPD Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: C9BC10C7500EEN
Market Monitor Global

Abstracts

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of death in the world.

This report contains market size and forecasts of COPD Therapeutics in Global, including the following market information:

Global COPD Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global COPD Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bronchodilators Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of COPD Therapeutics include GlaxoSmithKline, AstraZeneca, Theravance Biopharma and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COPD Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COPD Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global COPD Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Bronchodilators
• Inhaled Corticosteroids
• Other

Global COPD Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global COPD Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Adult
• Child

Global COPD Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global COPD Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies COPD Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies COPD Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• AstraZeneca
• Theravance Biopharma
• Mylan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 COPD Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global COPD Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COPD THERAPEUTICS OVERALL MARKET SIZE

2.1 Global COPD Therapeutics Market Size: 2021 VS 2028
2.2 Global COPD Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top COPD Therapeutics Players in Global Market
3.2 Top Global COPD Therapeutics Companies Ranked by Revenue
3.3 Global COPD Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 COPD Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies COPD Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 COPD Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 COPD Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 COPD Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global COPD Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Bronchodilators
  4.1.3 Inhaled Corticosteroids
  4.1.4 Other
4.2 By Type - Global COPD Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global COPD Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global COPD Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global COPD Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global COPD Therapeutics Market Size, 2021 & 2028
  5.1.2 Adult
  5.1.3 Child
5.2 By Application - Global COPD Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global COPD Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global COPD Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global COPD Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global COPD Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global COPD Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global COPD Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global COPD Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global COPD Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America COPD Therapeutics Revenue, 2017-2028
  6.3.2 US COPD Therapeutics Market Size, 2017-2028
  6.3.3 Canada COPD Therapeutics Market Size, 2017-2028
  6.3.4 Mexico COPD Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe COPD Therapeutics Revenue, 2017-2028
  6.4.2 Germany COPD Therapeutics Market Size, 2017-2028
  6.4.3 France COPD Therapeutics Market Size, 2017-2028
  6.4.4 U.K. COPD Therapeutics Market Size, 2017-2028
  6.4.5 Italy COPD Therapeutics Market Size, 2017-2028
  6.4.6 Russia COPD Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries COPD Therapeutics Market Size, 2017-2028
  6.4.8 Benelux COPD Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia COPD Therapeutics Revenue, 2017-2028
  6.5.2 China COPD Therapeutics Market Size, 2017-2028
  6.5.3 Japan COPD Therapeutics Market Size, 2017-2028
  6.5.4 South Korea COPD Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia COPD Therapeutics Market Size, 2017-2028
  6.5.6 India COPD Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America COPD Therapeutics Revenue, 2017-2028
  6.6.2 Brazil COPD Therapeutics Market Size, 2017-2028
  6.6.3 Argentina COPD Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa COPD Therapeutics Revenue, 2017-2028
  6.7.2 Turkey COPD Therapeutics Market Size, 2017-2028
  6.7.3 Israel COPD Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia COPD Therapeutics Market Size, 2017-2028
  6.7.5 UAE COPD Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline COPD Therapeutics Major Product Offerings
  7.1.4 GlaxoSmithKline COPD Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca COPD Therapeutics Major Product Offerings
  7.2.4 AstraZeneca COPD Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Theravance Biopharma
  7.3.1 Theravance Biopharma Corporate Summary
  7.3.2 Theravance Biopharma Business Overview
  7.3.3 Theravance Biopharma COPD Therapeutics Major Product Offerings
  7.3.4 Theravance Biopharma COPD Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Theravance Biopharma Key News
7.4 Mylan
  7.4.1 Mylan Corporate Summary
  7.4.2 Mylan Business Overview
  7.4.3 Mylan COPD Therapeutics Major Product Offerings
  7.4.4 Mylan COPD Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Mylan Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. COPD Therapeutics Market Opportunities & Trends in Global Market
Table 2. COPD Therapeutics Market Drivers in Global Market
Table 3. COPD Therapeutics Market Restraints in Global Market
Table 4. Key Players of COPD Therapeutics in Global Market
Table 5. Top COPD Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global COPD Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global COPD Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies COPD Therapeutics Product Type
Table 9. List of Global Tier 1 COPD Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 COPD Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global COPD Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - COPD Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - COPD Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global COPD Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - COPD Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - COPD Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global COPD Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global COPD Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global COPD Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America COPD Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America COPD Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe COPD Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe COPD Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia COPD Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia COPD Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America COPD Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America COPD Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa COPD Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa COPD Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline COPD Therapeutics Product Offerings
Table 32. GlaxoSmithKline COPD Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca COPD Therapeutics Product Offerings
Table 35. AstraZeneca COPD Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Theravance Biopharma Corporate Summary
Table 37. Theravance Biopharma COPD Therapeutics Product Offerings
Table 38. Theravance Biopharma COPD Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Mylan Corporate Summary
Table 40. Mylan COPD Therapeutics Product Offerings
Table 41. Mylan COPD Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. COPD Therapeutics Segment by Type in 2021
Figure 2. COPD Therapeutics Segment by Application in 2021
Figure 3. Global COPD Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global COPD Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global COPD Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by COPD Therapeutics Revenue in 2021
Figure 8. By Type - Global COPD Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global COPD Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global COPD Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America COPD Therapeutics Revenue Market Share, 2017-2028
Figure 12. US COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe COPD Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia COPD Therapeutics Revenue Market Share, 2017-2028
Figure 24. China COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America COPD Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa COPD Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE COPD Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline COPD Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca COPD Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Theravance Biopharma COPD Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mylan COPD Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)